Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.

2 Nov 2017

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients

Albert Einstein College of Medicine researchers report that the composition of people's gut bacteria may explain why some of them suffer life-threatening reactions after taking a key drug for treating metastatic colorectal cancer.

1 Nov 2017

Cleveland Clinic researcher awarded $2.6 million grant to create innovative models of colorectal cancer

Cleveland Clinic researcher Emina Huang, M.D., a colorectal surgeon in the Digestive Disease and Surgery Institute and a staff member in the Lerner Research Institute's Department of Stem Cell Biology and Regenerative Medicine, has been awarded a collaborative five-year, $2.6 million grant from the National Cancer Institute to create innovative models of colorectal cancer that will enhance understanding of how the disease develops and spreads.

31 Oct 2017

Air pollution linked to mortality from kidney, bladder and colorectal cancer

Air pollution is classified as carcinogenic to humans given its association with lung cancer, but there is little evidence for its association with cancer at other body sites. In a new large-scale prospective study led by the Barcelona Institute of Global Health, an institution supported by the "la Caixa" Foundation, and the American Cancer Society, researchers observed an association between some air pollutants and mortality from kidney, bladder and colorectal cancer.

31 Oct 2017

Artificial intelligence to support cancer detection, study says

A novel artificial intelligence powered endoscopic system developed in Japan has been proved to automatically detect colorectal adenomas at the time of colonoscopy.

30 Oct 2017

Fight CRC and CRI announce publication of ‘A Blueprint to Advance Colorectal Cancer Immunotherapies’

Fight Colorectal Cancer and the Cancer Research Institute, are proud to announce "A Blueprint to Advance Colorectal Cancer Immunotherapies" will be published in the November 2017 issue of the journal Cancer Immunology Research (published online ahead of print on October 16, 2017).

24 Oct 2017

APC gene mutations play dual role in development of colorectal cancer, research suggests

Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis. Research led by scientists at the Institut Pasteur and Inserm have recently demonstrated that mutations to this gene do not only lead to the emergence of colon polyps; they also harm the immune system, leaving it unable to tackle inflammation of the colonic mucosa.

24 Oct 2017

Study finds lung cancer driver ALK-fusion in mucosal melanoma

Melanomas caused by sun exposure have been matched with targeted treatments and immunotherapies, in many cases dramatically extending patients' lives. However, there are other kinds of melanoma not related to sun exposure and because they are caused by different genetic changes, they are not susceptible to the same targeted treatments.

23 Oct 2017

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

20 Oct 2017

Researchers use nanopore technique to detect biomarkers of disease

Adam Hall, Ph.D., isn't kidding when he says the research he does is on a very small scale. But he is understating things more than just a little.

20 Oct 2017

Study finds underlying causes of racial, ethnic disparities in cancer survival

Racial/ethnic disparities in cancer survival in the U.S. are well documented, but the underlying causes are not well understood. To better explain disparities, researchers examined cancer survival by racial/ethnic group for 877,662 patients diagnosed with breast, prostate, colorectal or lung cancer between 2000–2013 using California Cancer Registry data.

19 Oct 2017

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.

16 Oct 2017

Study finds lower cancer screening rates for workers at smaller companies

A new study by American Cancer Society investigators finds workers at organizations with fewer than 25 employees are less likely to have been screened for three cancers, as were people working in certain occupations. The study appears in Preventive Medicine.

12 Oct 2017

Combination of serrated polyps and high-risk adenomas may increase odds for colorectal cancer

Most colorectal cancer develops from precursors known as polyps, the most common and well researched of which are conventional adenomas. Conventional adenomas often progress to colorectal cancer through an intermediate step called high-risk adenomas.

11 Oct 2017

Five new ways individualized medicine has moved from research lab into clinical care

Advancements in individualized medicine are offering health care providers new tools to quickly and accurately diagnose, treat, predict and, eventually, prevent disease. Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, today outlined five new ways individualized medicine has moved from the research lab into clinical care. Dr. Stewart made his statements during the opening of the 2017 "Individualizing Medicine Conference: Advancing Care Through Genomics" in Rochester.

9 Oct 2017

Cancers linked to obesity account for 40% of all cancers in the US, report states

Being obese or overweight is linked to an increased risk of developing 13 types of cancer, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute. These cancers accounted for approximately 40% of all cancers diagnosed in the US, in 2014.

4 Oct 2017

Non-labeling multiphoton microscopy provides highly reliable prediction of cancer malignancy

A new study by Osaka University scientists shows that non-labeling multiphoton microscopy (NL-MPM) can be used for quantitative imaging of cancer that is safe and requires no resection, fixation or staining of tissues.

3 Oct 2017

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Experts from United European Gastroenterology (UEG), presenting at the European Digestive Cancer Days Conference in Prague today, are calling on European governments to focus their efforts on developing early diagnosis techniques, in order to save thousands of lives from digestive cancers including a more targeted approach to ensure at risk patients don’t ‘slip through the early-detection net’.

28 Sep 2017

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors.

28 Sep 2017

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Researchers develop new, three-step system to eliminate colorectal cancer

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients

Cleveland Clinic researcher awarded $2.6 million grant to create innovative models of colorectal cancer

Air pollution linked to mortality from kidney, bladder and colorectal cancer

Artificial intelligence to support cancer detection, study says

Fight CRC and CRI announce publication of ‘A Blueprint to Advance Colorectal Cancer Immunotherapies’

APC gene mutations play dual role in development of colorectal cancer, research suggests

Study finds lung cancer driver ALK-fusion in mucosal melanoma

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Researchers use nanopore technique to detect biomarkers of disease

Study finds underlying causes of racial, ethnic disparities in cancer survival

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

Study finds lower cancer screening rates for workers at smaller companies

Combination of serrated polyps and high-risk adenomas may increase odds for colorectal cancer

Five new ways individualized medicine has moved from research lab into clinical care

Cancers linked to obesity account for 40% of all cancers in the US, report states

Non-labeling multiphoton microscopy provides highly reliable prediction of cancer malignancy

Benefits of Biomarkers in Colorectal Cancer Treatment

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in